Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19

Authors

Sahar Ashraf, Northpointe Psychiatry
Nauman Ashraf, Kansas City UniversityFollow

Document Type

Letter to the Editor

Publication Title

JAMA

DOI

10.1001/jama.2023.5061

Publication Date

5-16-2023

Keywords

COVID-19

ISSN

1538-3598

Recommended Citation

Ashraf S, Ashraf N. Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19. JAMA. 2023; 329(19). doi: 10.1001/jama.2023.5061.